Wells Fargo Maintains Overweight on Insulet, Lowers Price Target to $255
Insulet Corporation
Insulet Corporation PODD | 0.00 |
Wells Fargo analyst Lawrence Biegelsen maintains Insulet (NASDAQ:
PODD) with a Overweight and lowers the price target from $360 to $255.